Not Yet RecruitingNot Applicable

EFFECT OF PLAZEPOD VERSUS ELECTRICAL STIMULATION ON RISK OF FALLING IN HEMODIALYSIS PATIENTS

Egypt60 participantsStarted 2026-03-21

Plain-language summary

Renal nutrition Fluid control Safe physical activity Sleep hygiene, energy and managing fatigue Adherence and awareness

Who can participate

Age range40 Years – 50 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * : * Male patients aged 40 to 50 years. * Diagnosed with end-stage renal disease and receiving maintenance hemodialysis for at least 6 months. * Medically stable and cleared by a nephrologist to participate in physical activity and/or electrical stimulation. * Able to ambulate independently or with minimal assistance. * Cognitively able to understand study procedures. * Not participating in any other structured exercise program. Exclusion Criteria: * Severe neurological or orthopedic disorders affecting mobility. * Unstable cardiovascular conditions. * Cognitive impairment or sensory deficits. * Contraindications to neuromuscular electrical stimulation.

What they're measuring

Risk of Falling Assessed by Timed Up and Go Test (TUG)

Timeframe: Baseline and after 12 weeks of intervention

Balance Performance Assessed by Berg Balance Scale (BBS)

Timeframe: Baseline and after 12 weeks

Lower Limb Muscle Strength

Timeframe: Baseline and after 12 weeks

Trial details

NCT IDNCT07380191

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-22

Contact for this trial

Samia Wagdy El said Diab, PHD

01094762028 Samiaahmeddiab@gmail.com

View on ClinicalTrials.gov More Fall Risk, Fall Prevention trials